Department of Rehabilitation and Health Services, University of North Texas, Denton, Texas, United States of America.
Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, California, United States of America.
PLoS One. 2024 Jan 2;19(1):e0296434. doi: 10.1371/journal.pone.0296434. eCollection 2024.
Alpha-1 antitrypsin deficiency (AATD) is related to developing lung and liver disease, but no large-scale studies examine its association with birth outcomes.
We investigated the risk of pregnancy complications and adverse birth outcomes in mothers and children with AATD.
Using a large cohort data of Danish mothers and children with AATD from 1973 to 2013 (n = 2,027,229), with 559 cases (305 mothers and 254 children). We conducted Poisson regression to examine associations between alpha-1 antitrypsin deficiency, adverse birth outcomes, and pregnancy complications in mothers and children.
AATD was related to term low birth weight [<2500g; Risk Ratio(RR) = 2.04, 95% confidence interval (CI): 1.50-2.79], lowest quartile of abdominal circumference at birth in children of non-smoking mothers (RR = 1.55, 95% CI: 1.14-2.11), delivery via Cesarean-section (RR = 1.59, 95% CI: 1.05-2.40), preterm birth (RR = 1.54, 95% CI: 1.19-2.00) and preeclampsia (RR = 2.64, 95% CI: 1.76-3.94).
This emphasizes the need for mothers with AATD to be monitored closely during pregnancy to reduce the risk of adverse birth outcomes. Routine screening for alpha-1 antitrypsin in pregnancy may be considered among mothers with a pulmonary and liver disease history.
α-1 抗胰蛋白酶缺乏症(AATD)与肺部和肝脏疾病有关,但尚无大规模研究探讨其与出生结局的关系。
我们研究了 AATD 母亲和儿童的妊娠并发症及不良出生结局风险。
利用丹麦 1973 年至 2013 年期间患有 AATD 的母亲和儿童的大型队列数据(n=2027229 例,559 例,其中 305 例为母亲,254 例为儿童),采用泊松回归分析探讨 AATD 与不良出生结局和妊娠并发症之间的关系。
AATD 与足月低出生体重[<2500g;风险比(RR)=2.04,95%置信区间(CI):1.50-2.79]、非吸烟母亲儿童出生时腹围最低四分位数(RR=1.55,95%CI:1.14-2.11)、剖宫产分娩(RR=1.59,95%CI:1.05-2.40)、早产(RR=1.54,95%CI:1.19-2.00)和子痫前期(RR=2.64,95%CI:1.76-3.94)相关。
这强调了需要对患有 AATD 的母亲进行密切监测,以降低不良出生结局的风险。对于有肺部和肝脏疾病病史的母亲,可考虑在孕期常规筛查α-1 抗胰蛋白酶。